The NADase CD38 is a central regulator in gouty inflammation and a novel druggable therapeutic target
Paulo Vinícius Gil Alabarse(VA San Diego Healthcare System), Ru Liu‐Bryan(University of California San Diego)
Cited by 12
Related Papers
Linked decreases in liver kinase B1 and AMP-activated protein kinase activity modulate matrix catabolic responses to biomechanical injury in chondrocytes
|Arthritis Research & Therapy|2013|104
C/EBP homologous protein drives pro-catabolic responses in chondrocytes
|Arthritis Research & Therapy|2013|68
Arhalofenate acid inhibits monosodium urate crystal-induced inflammatory responses through activation of AMP-activated protein kinase (AMPK) signaling
|Arthritis Research & Therapy|2018|46
Modulation of matrix metabolism by ATP-citrate lyase in articular chondrocytes
|Journal of Biological Chemistry|2018|26